EPIQ PARTNERS, LLC Buys 2, Sells 3 in 2nd Quarter

EPIQ PARTNERS, LLC recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

2919 KNOX AVENUE S MINNEAPOLIS, MN 55408

As of the latest 13F report, the guru’s equity portfolio contained 79 stocks valued at a total of $154.00Mil. The top holdings were HRL(12.64%), HBAN(3.57%), and ALB(3.51%).

According to GuruFocus data, these were EPIQ PARTNERS, LLC’s top five trades of the quarter.

Special Opportunities Fund Inc


EPIQ PARTNERS, LLC reduced their investment in NYSE:SPE by 388,879 shares. The trade had a 3.4% impact on the equity portfolio. During the quarter, the stock traded for an average price of $14.79.

On 07/07/2022, Special Opportunities Fund Inc traded for a price of $12.73 per share and a market cap of $161.84Mil. The stock has returned -5.52% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 2 out of 10.

In terms of valuation, Special Opportunities Fund Inc has a price-earnings ratio of 2.74, a price-book ratio of 0.77 and a price-sales ratio of 3.66.

Janus Henderson B-BBB CLO ETF


The guru established a new position worth 91,480 shares in BATS:JBBB, giving the stock a 2.58% weight in the equity portfolio. Shares traded for an average price of $49.52 during the quarter.

On 07/07/2022, Janus Henderson B-BBB CLO ETF traded for a price of $45.195 per share and a market cap of $79.09Mil. The stock has returned 0.00% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, Janus Henderson B-BBB CLO ETF has a price-earnings ratio of 10.68 and a price-book ratio of 2.65.

BlackRock Innovation & Growth Tr


The guru established a new position worth 229,293 shares in NYSE:BIGZ, giving the stock a 1.5% weight in the equity portfolio. Shares traded for an average price of $12.61 during the quarter.

On 07/07/2022, BlackRock Innovation & Growth Tr traded for a price of $8.59 per share and a market cap of $2.04Bil. The stock has returned 0.00% over the past year.

GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 1 out of 10.

Janus Henderson AAA CLO ETF


EPIQ PARTNERS, LLC reduced their investment in ARCA:JAAA by 21,820 shares. The trade had a 0.62% impact on the equity portfolio. During the quarter, the stock traded for an average price of $50.22.

On 07/07/2022, Janus Henderson AAA CLO ETF traded for a price of $48.99 per share and a market cap of $1.42Bil. The stock has returned -1.95% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

ETFMG Sit Ultra Short ETF


EPIQ PARTNERS, LLC reduced their investment in ARCA:VALT by 11,900 shares. The trade had a 0.33% impact on the equity portfolio. During the quarter, the stock traded for an average price of $49.27.

On 07/07/2022, ETFMG Sit Ultra Short ETF traded for a price of $48.605 per share and a market cap of $224.80Mil. The stock has returned -1.55% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.